Colin Hartman

Ackerman lab

Colin received his B.S. in Molecular Biology from Northern Kentucky University. During his undergraduate studies, he investigated a novel decontamination method for Pseudogymnoascus destructans, the causative fungus of white-nose syndrome in bats. He also worked at the Université de Rennes 1 in Rennes, France, to investigate the epigenetic effects of pesticide exposure on mammals. After graduating in 2020, Colin joined Margie Ackerman's lab in the Microbiology and Immunology department here at Dartmouth. He now works on developing a platform for the generation of patient-customized monoclonal antibody therapies for cancer patients. Colin is also a Dartmouth Ph.D. Innovation Fellow. Outside of the lab, he enjoys soccer, skiing, and board games.


HB Hinman Box 8000

Selected Publications

  • Hartman C, Legoff L, Capriati M, Lecuyer G, Kernanec P-Y, Tevosian S, D'cruz S, and Smagulova F (2021). Epigenetic effects promoted by neonicotinoid thiacloprid exposure. Front Cell Dev Biol.

    Hartman C, Mester J, Hare P, Cohen A (2020) Novel inactivation of the causative fungal pathogen of white-nose syndrome with methoxsalen plus ultraviolet A or B radiation. PLOS ONE.